<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuroprotective benefit of intra-operative <z:chebi fb="37" ids="38867">anesthetics</z:chebi> is widely described and routinely aimed to invoke electroencephalographic (EEG) silence in anticipation of transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous rat survival studies have questioned an additional benefit from achieving EEG silence during transient global <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Surgical preparation on twelve New Zealand white rabbits under ketamine-<z:chebi fb="3" ids="44915">propofol</z:chebi> anesthesia, included placement of skull screws for bilateral EEG monitoring, skull shaving for laser Doppler probes, and a 5 mm diameter right temporal craniotomy for the <z:chebi fb="0" ids="16908">NADH</z:chebi> probe </plain></SENT>
<SENT sid="3" pm="."><plain>Transient global <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> was achieved with bilateral internal carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and pharmacologically induced systemic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> animals acted as controls, and had <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> under baseline <z:chebi fb="3" ids="44915">propofol</z:chebi> anesthesia with an active EEG </plain></SENT>
<SENT sid="5" pm="."><plain>Thereafter, animals were randomized to receive bolus injection of intracarotid (3-5 mg) or intravenous (10-20 mg) 1% <z:chebi fb="3" ids="44915">propofol</z:chebi> to create EEG silence for 1-2 min </plain></SENT>
<SENT sid="6" pm="."><plain>The data collected at baseline, peak hypoperfusion, and 5 and 10 min post hypoperfusion was analyzed by repeated measures ANOVA with post hoc Bonferroni-Dunn test </plain></SENT>
<SENT sid="7" pm="."><plain>Eleven of the twelve rabbits completed the protocol </plain></SENT>
<SENT sid="8" pm="."><plain>Hemodynamics and cerebral blood flow changes were comparable in <z:hpo ids='HP_0000001'>all</z:hpo> the animals </plain></SENT>
<SENT sid="9" pm="."><plain>Compared to controls, the increase in <z:chebi fb="0" ids="16908">NADH</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was unaffected by EEG silence with either intravenous or intraarterial <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>We failed to observe any significant additional attenuation of the elevation in <z:chebi fb="0" ids="16908">NADH</z:chebi> levels with <z:chebi fb="3" ids="44915">propofol</z:chebi> induced EEG silence during transient global <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>This is consistent with previous rat survival studies showing that EEG silence was not required for full neuroprotective effects of pentothal anesthesia </plain></SENT>
</text></document>